Replimune Group logo
Replimune Group REPL
€ 8.16 -3.85%

Quartalsbericht 2025-Q4
hinzugefügt 03.02.2026

report update icon

Replimune Group Kurzfristige Verbindlichkeiten 2011-2026 | REPL

Kurzfristige Verbindlichkeiten Jährlich Replimune Group

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
62.4 M 40.4 M 33.8 M 20.8 M 14.5 M 11.9 M 9.88 M - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
62.4 M 9.88 M 27.7 M

Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name Kurzfristige Verbindlichkeiten Preis % 24h Marktkapitalisierung Land
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
6.4 M - 1.35 % $ 17.8 M chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
3.56 M - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
100 M - - $ 2.18 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
22.6 M $ 2.08 -6.53 % $ 194 M israelIsrael
Coherus BioSciences Coherus BioSciences
CHRS
140 M $ 1.46 -7.34 % $ 171 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Athira Pharma Athira Pharma
ATHA
47.5 M - - $ 269 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
149 M $ 51.91 -8.85 % $ 4.67 B schweizSchweiz
Galera Therapeutics Galera Therapeutics
GRTX
645 K - -32.59 % $ 7.61 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
9.38 M - - $ 231 M usaUSA
Berkeley Lights Berkeley Lights
BLI
45.5 M - -7.31 % $ 87 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
51 M $ 28.72 -4.04 % $ 1.91 B usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
35.1 M - - $ 344 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
9.02 M $ 0.72 -8.97 % $ 32.9 M israelIsrael
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
Esperion Therapeutics Esperion Therapeutics
ESPR
301 M $ 3.14 0.16 % $ 653 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
38.5 M $ 29.23 1.14 % $ 787 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
1.33 M - -4.36 % $ 27 M usaUSA
Forte Biosciences Forte Biosciences
FBRX
20.8 M $ 16.07 -3.71 % $ 208 M usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
31 M - - $ 384 M britainBritain
Gracell Biotechnologies Gracell Biotechnologies
GRCL
221 M - - $ 3.37 B chinaChina
Anika Therapeutics Anika Therapeutics
ANIK
21.9 M $ 14.53 -1.76 % $ 208 M usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
1.61 M - 1.93 % $ 17.4 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.73 M $ 3.1 -1.9 % $ 5.1 M israelIsrael
Aptose Biosciences Aptose Biosciences
APTO
9.31 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
6.29 M - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
AlloVir AlloVir
ALVR
9.71 M - 4.14 % $ 49.1 M usaUSA